lapatinib
Showing 1 - 25 of 371
Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)
Recruiting
- Ovarian Cancer
- Lapatinib and Paclitaxel
-
Lexington, KentuckyMarkey Cancer Center
Dec 2, 2022
Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine
Completed
- Breast Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 30, 2022
Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)
Completed
- Breast Cancer
- Cardiac Toxicity
- trastuzumab
- +11 more
-
Rochester, MinnesotaMayo Clinic Cancer Research Consortium
Jul 12, 2022
Metastatic Triple Negative Breast Cancer Trial in Birmingham (Combination of Veliparib + Lapatinib)
Active, not recruiting
- Metastatic Triple Negative Breast Cancer
- Combination of Veliparib + Lapatinib
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 25, 2022
Metastatic Pancreatic Cancer Trial in Providence (Gemcitabine 1000mg/m2 30 minutes, Lapatinib 1000mg/d, Lapatinib 1500mg/d)
Terminated
- Metastatic Pancreatic Cancer
- Gemcitabine 1000mg/m2 30 minutes
- +4 more
-
Providence, Rhode IslandLifespan Hospitals
Jan 5, 2022
Newly Diagnosed Glioblastoma Multiforme Trial in Los Angeles (Lapatinib/Temozolomide/radiation)
Active, not recruiting
- Newly Diagnosed Glioblastoma Multiforme
- Lapatinib/Temozolomide/radiation
-
Los Angeles, CaliforniaUCLA
Jan 5, 2022
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)
Terminated
- Breast Neoplasms
- +2 more
- letrozole
- +2 more
-
Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Active, not recruiting
- Breast Cancer
- Lapatinib
- +2 more
-
Birmingham, Alabama
- +7 more
May 15, 2022
Metastatic Breast Cancer Trial in Durham (dHER2 + AS15 ASCI, Lapatinib)
Completed
- Metastatic Breast Cancer
- dHER2 + AS15 ASCI
- Lapatinib
-
Durham, North CarolinaDuke University Medical Center
Nov 18, 2021
Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))
Recruiting
- Cancer
- Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Jul 18, 2022
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Los Angeles (drug, biological, other)
Terminated
- HER2-positive Breast Cancer
- +2 more
- capecitabine
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 22, 2021
Tumors, Breast Trial in China, Hong Kong (lapatinib, capecitabine)
Terminated
- Neoplasms, Breast
- lapatinib
- capecitabine
-
Guangzhou, Guangdong, China
- +10 more
Aug 26, 2021
Breast Cancer Trial in Beijing (Hemay022+AI, Lapatinib+Capecitabine)
Recruiting
- Breast Cancer
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 1, 2022
Lapatinib Resistant HER2-Positive Metastatic Breast Cancer
Active, not recruiting
- Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangsu Provincial People's Hospital
May 19, 2021
Non-HPV Locally Advanced Head Neck Cancer Trial in Canada, United States (IMRT, Cisplatin, )
Active, not recruiting
- Non-HPV Locally Advanced Head and Neck Cancer
- IMRT
- +3 more
-
Birmingham, Alabama
- +15 more
Oct 29, 2021
NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- AZD6244
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Tumors, Breast Trial in France, Ireland, United States (lapatinib, docetaxel, trastuzumab)
Terminated
- Neoplasms, Breast
- lapatinib, docetaxel, trastuzumab
-
Nashville, Tennessee
- +4 more
Jun 30, 2022
Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))
Recruiting
- Malignant Solid Neoplasms
- Nilotinib (400 mg BID)
- +6 more
-
Bordeaux, France
- +6 more
Dec 15, 2022
Tumors, Breast Trial in Worldwide (lapatinib (GW572016) oral tablets, paclitaxel infusion)
Completed
- Neoplasms, Breast
- lapatinib (GW572016) oral tablets
- paclitaxel infusion
-
Salvador, BahÃa, Brazil
- +53 more
Jan 18, 2022
Vestibular Schwannoma, NF2, Neurofibromatosis 2 Trial in United States (lapatinib)
Completed
- Vestibular Schwannoma
- +4 more
- lapatinib
-
Los Angeles, California
- +6 more
Dec 22, 2020
Metastatic Breast Cancer, CNS (CNS) Metastases Trial in United States (Lapatinib in Tandem With Capecitabine)
Completed
- Metastatic Breast Cancer
- Central Nervous System (CNS) Metastases
- Lapatinib in Tandem With Capecitabine
-
Ann Arbor, Michigan
- +8 more
Jan 25, 2021